Arlet G, Brami G, Décrè D, Flippo A, Gaillot O, Lagrange P H, Philippon A
Service de Microbiologie, Hôpital Saint-Louis, Paris, France.
FEMS Microbiol Lett. 1995 Dec 15;134(2-3):203-8. doi: 10.1111/j.1574-6968.1995.tb07938.x.
To rapidly characterise TEM-derived extended-spectrum beta-lactamases a fast and easy method using polymerase chain reaction-restriction fragment length polymorphism was developed. This method was validated with ten reference TEM-type extended-spectrum beta-lactamases. The mutations involved in TEM-20 and TEM-21, which were previously reported only with biochemical analysis, were then characterised. TEM-20 differed from TEM-19 by a silent mutation at position 925 (A for G), and TEM-21 differed from TEM-3 and TEM-14 by a single mutation (G for A) in an unreported position 660. beta-lactamase conferring low resistance to ceftazidime (TEM-29), was described. TEM-29 derived from TEM-1, with an amino acid substitution, his-164. Finally, the combination of polymerase chain reaction-restriction fragment length polymorphism and plasmid analysis allowed us to investigate nosocomial outbreaks due to clinical isolates of multi-resistant Klebsiella pneumoniae in three hospitals.
为了快速鉴定由TEM衍生的超广谱β-内酰胺酶,开发了一种使用聚合酶链反应-限制性片段长度多态性的快速简便方法。该方法用十种参考TEM型超广谱β-内酰胺酶进行了验证。然后对先前仅通过生化分析报道的TEM-20和TEM-21中涉及的突变进行了鉴定。TEM-20与TEM-19的区别在于第925位的沉默突变(A替换为G),TEM-21与TEM-3和TEM-14的区别在于未报道的第660位的单个突变(G替换为A)。描述了对头孢他啶耐药性较低的β-内酰胺酶(TEM-29)。TEM-29由TEM-1衍生而来,有一个氨基酸替代,即组氨酸-164。最后,聚合酶链反应-限制性片段长度多态性和质粒分析的结合使我们能够调查三家医院中多重耐药肺炎克雷伯菌临床分离株引起的医院感染暴发。